205 related articles for article (PubMed ID: 37704682)
1. FAM3 family genes are associated with prognostic value of human cancer: a pan-cancer analysis.
Dong QT; Ma DD; Gong Q; Lin ZY; Li ZH; Ye JX; Qin CH; Jin WD; Zhang JX; Zhang ZY
Sci Rep; 2023 Sep; 13(1):15144. PubMed ID: 37704682
[TBL] [Abstract][Full Text] [Related]
2. FAM3 Family as Prognostic Factors for Head and Neck Squamous Cell Carcinoma.
Liao C; Wang Q; An J; Wang H; Xiao L; Long Q; Zhao H; Liu J; Guan X
Comb Chem High Throughput Screen; 2023; 26(3):539-558. PubMed ID: 35538834
[TBL] [Abstract][Full Text] [Related]
3. Pan-Cancer Prognostic, Immunity, Stemness, and Anticancer Drug Sensitivity Characterization of N6-Methyladenosine RNA Modification Regulators in Human Cancers.
Li R; Yin YH; Ji XL; Liu X; Li JP; Qu YQ
Front Mol Biosci; 2021; 8():644620. PubMed ID: 34150845
[TBL] [Abstract][Full Text] [Related]
4. Identification of Potential Indicators for Survival in Patients with Thyroid Cancer Based on Expression of FAM3 Members.
Ma Y; Shi J; Liu Y; Cui W; Pan R; Qiu H; Han F; Hou N; Sun X
Crit Rev Eukaryot Gene Expr; 2023; 33(4):39-52. PubMed ID: 37183945
[TBL] [Abstract][Full Text] [Related]
5. Pan-Cancer Analysis on the Oncogenic Role of Programmed Cell Death 10.
Sun N; Li C; Teng Y; Deng Y; Shi L
J Oncol; 2022; 2022():1242658. PubMed ID: 36276268
[TBL] [Abstract][Full Text] [Related]
6. Integrative analysis revealed a correlation of PIAS family genes expression with prognosis, immunomodulation and chemotherapy.
Zhang Q; Zhang J; Lan T; He J; Lei B; Wang H; Mei Z; Lv C
Eur J Med Res; 2024 Mar; 29(1):195. PubMed ID: 38528630
[TBL] [Abstract][Full Text] [Related]
7. Prognostic, immunity, stemness, and anticancer drug sensitivity characterization of pyroptosis related genes in non-small cell lung cancer.
Xu C; Ma H; Chen J; Li X; Wang Z; Hu B; Zhang N; Meng F
Thorac Cancer; 2024 Jan; 15(3):215-226. PubMed ID: 38115677
[TBL] [Abstract][Full Text] [Related]
8. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
Huang S; Sun L; Hou P; Liu K; Wu J
Front Immunol; 2022; 13():944898. PubMed ID: 36148220
[TBL] [Abstract][Full Text] [Related]
9. Systematic analysis of the role of LDHs subtype in pan-cancer demonstrates the importance of LDHD in the prognosis of hepatocellular carcinoma patients.
Wang S; Wu X; Wu X; Cheng J; Chen Q; Qi Z
BMC Cancer; 2024 Jan; 24(1):156. PubMed ID: 38291366
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive analysis and validation of cuproptosis-associated genes across cancers: Overall survival, the tumor microenvironment, stemness scores, and drug sensitivity.
Liu J; Lu Y; Dai Y; Shen Y; Zeng C; Liu X; Yu H; Deng J; Lu W
Front Genet; 2022; 13():939956. PubMed ID: 36105090
[No Abstract] [Full Text] [Related]
11.
Zhu Y; Pu Z; Wang G; Li Y; Wang Y; Li N; Peng F
Biomark Med; 2021 Apr; 15(5):373-384. PubMed ID: 33666514
[TBL] [Abstract][Full Text] [Related]
12. Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy.
Zhang J; Wang K; Hainisayimu T; Li H
Oxid Med Cell Longev; 2022; 2022():9614819. PubMed ID: 36046686
[TBL] [Abstract][Full Text] [Related]
13. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
14. A pan-cancer analysis revealing the role of LFNG, MFNG and RFNG in tumor prognosis and microenvironment.
Gong X; Zheng C; Jia H; Liu Y; Yang R; Chen Z; Pan Y; Li X; Liu Y
BMC Cancer; 2023 Nov; 23(1):1065. PubMed ID: 37932706
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and immune infiltrative biomarkers of CENPO in pan-cancer and its relationship with lung adenocarcinoma cell proliferation and metastasis.
Wang Y; Ye D; Li Y; Lv F; Shen W; Li H; Tian L; Fan Z; Li Y; Wang Y; Li F; Chen Y
BMC Cancer; 2023 Aug; 23(1):735. PubMed ID: 37558987
[TBL] [Abstract][Full Text] [Related]
16. Pan-Cancer Analysis Based on
Zhang Y; Wang S; Han S; Feng Y
Front Oncol; 2022; 12():844794. PubMed ID: 35359375
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features, prognostic significance, and associated tumor cell functions of family with sequence similarity 111 member B in pancreatic adenocarcinoma.
Gong Q; Dong Q; Zhong B; Zhang T; Cao D; Zhang Y; Ma D; Cai X; Li Z
J Clin Lab Anal; 2022 Dec; 36(12):e24784. PubMed ID: 36408702
[TBL] [Abstract][Full Text] [Related]
18.
Kuang W; Wang X; Ding J; Li J; Ji M; Chen W; Wang L; Yang P
Front Immunol; 2022; 13():805311. PubMed ID: 35154122
[TBL] [Abstract][Full Text] [Related]
19. TMX family genes and their association with prognosis, immune infiltration, and chemotherapy in human pan-cancer.
Luo N; Mei Z; Zhang Q; Tang H; Wan R; Deng A; Zou X; Lv C
Aging (Albany NY); 2023 Dec; 15(24):15064-15083. PubMed ID: 38147024
[TBL] [Abstract][Full Text] [Related]
20. FAM3C in Cancer-Associated Adipocytes Promotes Breast Cancer Cell Survival and Metastasis.
Kim S; Oh J; Park C; Kim M; Jo W; Kim CS; Cho SW; Park J
Cancer Res; 2024 Feb; 84(4):545-559. PubMed ID: 38117489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
